Literature DB >> 3948137

Treatment of hairy cell leukemia with alpha interferons.

J R Quesada, J U Gutterman, E M Hersh.   

Abstract

A review of clinical research with alpha interferons in the treatment of hairy cell leukemia is presented. The results of several studies have shown that alpha interferons effectively reduce leukemic infiltrates in the bone marrow and other organs, with attendant resolution of cytopenias. Alpha interferons have shown efficacy in the treatment of patients in all clinical stages of the disease, including those previously untreated, and may become the treatment choice for hairy cell leukemia. Hairy cell leukemia will also provide a useful human clinical model in which some of the fundamental mechanisms of interferon activity can be studied.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948137     DOI: 10.1002/1097-0142(19860415)57:8+<1678::aid-cncr2820571308>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

Review 1.  The optimal management of hairy cell leukaemia.

Authors:  R Gollard; T C Lee; L D Piro; A Saven
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

2.  Bioactivity determination of native and variant forms of therapeutic interferons.

Authors:  Louise Larocque; Alex Bliu; Ranran Xu; Abebaw Diress; Junzhi Wang; Rongtuan Lin; Runtao He; Michel Girard; Xuguang Li
Journal:  J Biomed Biotechnol       Date:  2011-03-03

3.  In vitro beta 2-microglobulin (beta 2m) secretion by normal and leukaemic B-cells: effects of recombinant cytokines and evidence for a differential response to the combined stimulus of phorbol ester and calcium ionophore.

Authors:  R A Jones; H G Drexler; S M Gignac; J A Child; C S Scott
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.